Johnson, B. et al. 2022. Epidermal Growth Factor Receptor Inhibitor Treatment Timing does not Impact Survival in Stage 4 Colon Cancer Treatment: A Retrospective Study: EGFR Inhibitor Treatment Line Outcomes. Kansas Journal of Medicine. 15, 2 (Aug. 2022), 273–277. DOI:https://doi.org/10.17161/kjm.vol15.15975.